Navigation Links
Animal, human health benefits anticipated from university's premier biomedical instrument
Date:11/12/2013

MANHATTAN, Kan. -- A Kansas State University team recently received a nearly $1.3 million grant from the National Science Foundation's Major Research Institute for a biomedical instrument that is anticipated to help with breakthroughs in animal and human health as well as cancer treatment.

The instrument is a modified wide-bore 600-megahertz magnetic resonance imaging spectrometer that will be equipped with a custom imaging probe. It can heat specific cells in the body using a process called thermal cell therapy that mimics how the body uses fever to fight infections while simultaneously producing real-time, high-resolution images of the heat's effects on tumors and inflamed cells.

"There is not a single instrument in the U.S. with which you can heat specific living cells and then image those cells to see immediately what effects that heat has," said Stefan Bossmann, professor of chemistry. "With this, we can see heat therapy with cell therapy in action."

The instrument will be used to treat small animal patients with cancers, infections and other diseases. Heat therapy of large animals and humans is anticipated to follow. Patients are not harmed by the instrument, Bossmann said.

The technology may eventually enable personalized hyperthermia treatment for infectious diseases and cancers in both humans and animals.

"We're excited because now we can use the instrument's very high-resolution images to track the cells and see the effects that heat and cell mediated therapy have on the tumor," said Deryl Troyer, professor of anatomy and physiology. "The key is that as we get feedback from the instrument, we can fine-tune it and refine this treatment method to a greater extent."

The project includes Bossmann; Troyer; Leila Maurmann, nuclear magnetic resonance/instrumentation manager of the chemistry department; Punit Prakash, assistant professor of electrical and computer engineering; and Sanjeev Narayanan, associate professor of diagnostic medicine and pathobiology.

Bossmann said the longstanding interdisciplinary collaborations and research projects between departments and colleges were key in Kansas State University winning this competitive national grant.

Prakash will develop a unique MRI probe, making it possible for the device to both produce high-resolution images and conduct targeted thermal cell therapy. He also will be responsible for system integration.

Maurmann is helping customize the instrument during its manufacturing process. It is anticipated to be complete in summer 2014. She will be responsible for the health of the biomedical instrument during and after installation.

Bossmann, Troyer and colleagues will use the instrument in their hyperthermia nanoparticle research. Stem cells from umbilical cords as well as defensive cells are used to cloak magnetic nanoparticles and traffic them to tumors. A radiofrequency field heats the nanoparticles, overheating the tumor and killing it.

Additionally, it may be possible to modify the instrument in the future so it can help treat heart disease and other cardiovascular diseases.

Narayanan plans to use the instrument to help treat Fusobacterium necrophorum infections and tuberculosis in cattle. The heat from the instrument may lead to discoveries about how to stop and to prevent bacterial infections that are impossible to treat with antibiotics.

"With this technology we can then start building integrated therapies," Bossmann said. "We have heat therapy, chemotherapeutics, can recruit defensive cells, and now will have an integrated piece of equipment that will be a springboard to do integrated therapy using these methods. There is no golden bullet to make advanced infectious diseases and cancer magically go away. They are systemic diseases and they have to be beaten with systemic methods."


'/>"/>

Contact: Stefan Bossmann
sbossman@k-state.edu
785-532-6817
Kansas State University
Source:Eurekalert  

Related medicine news :

1. New drug prevents spread of human prostate cancer cells
2. Scientists solving the mystery of human consciousness
3. First targeted nanomedicine to enter human clinical studies
4. Edith Mitchell, M.D., FACP, named 2012 recipient of ASCO Humanitarian Award
5. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
6. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
7. IBN discovers human neural stem cells with tumor targeting ability
8. RANK protein promotes the initiation, progression and metastasis of human breast cancer
9. CNIO researchers describe new functions of cohesin relevant for human disease
10. New Clues to the Evolution of the Human Brain
11. Humanist funerals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Animal, human health benefits anticipated from university's premier biomedical instrument
(Date:12/9/2016)... ... December 09, 2016 , ... Flottman Company ... outserts. As a means of expanding capabilities Flottman has added a G&K ... individually code professional inserts (PIs) and patient package inserts (PPIs) that will marry ...
(Date:12/9/2016)... Hills, CA (PRWEB) , ... December 09, 2016 ... ... for young adults, celebrated its 10th anniversary with the grand opening of the ... California. The successful event spanned two days, December 2-3, and was attended by ...
(Date:12/9/2016)... Fort Lee, NJ (PRWEB) , ... December 09, ... ... the 2016 Founders Ball at The Pierre Hotel in New York, NY, on ... 700 friends, benefactors, dignitaries and physicians attended the annual event, which raised over ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Pennsylvania Athletic ... (PCN) during the summer of 2016. The program was made possible by a ... States Department of Health and Human Services Administration. The broadcast, Use Your ...
(Date:12/8/2016)... ... December 08, 2016 , ... After ... officially opened registration today for its 33rd Annual Issues & Research Conference, ... , The theme of the conference is “Persistent Challenges and New Opportunities: Using ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... 2016 Research and Markets has announced the addition ... report to their offering. ... The report also analyses the market by the following Technology Types: ... for the US, Canada , Japan ... Latin America , and Rest of World. ...
(Date:12/9/2016)... 9, 2016 aTyr Pharma, Inc. (Nasdaq: LIFE ... Physiocrine-based therapeutics to address severe, rare diseases, today announced that senior ... Prescriptions for Success Healthcare Conference at the InterContinental Barclay Hotel in ... 2016, at 4:20 p.m. ET. About aTyr Pharma ... aTyr Pharma ...
(Date:12/9/2016)... 2016  Forge Therapeutics, Inc. today announced a ... EVT, TecDAX, ISIN: DE0005664809) to advance its novel ... of bacterial infections including those caused by drug ... attractive antibacterial target for more than the past ... starting points has hampered its progress. Forge has ...
Breaking Medicine Technology: